Announcement on Voluntary Disclosure of Multiple Clinical Research Results Selected as Reports for the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

About this update from Mabwell (shanghai) Bioscience Co., Ltd. Class A

Announcement on Voluntary Disclosure of Multiple Clinical Research Results Selected as Reports for the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Mabwell (shanghai) Bioscience Co., Ltd. Class A